Drug Interactions between Ferrlecit and heme iron polypeptide
This report displays the potential drug interactions for the following 2 drugs:
- Ferrlecit (sodium ferric gluconate complex)
- heme iron polypeptide
Interactions between your drugs
sodium ferric gluconate complex heme iron polypeptide
Applies to: Ferrlecit (sodium ferric gluconate complex) and heme iron polypeptide
GENERALLY AVOID: Parenteral iron therapy may reduce the absorption of concomitantly administered oral iron preparations.
MANAGEMENT: Parenteral iron preparations should not be administered concomitantly with oral iron preparations. Patients should wait at least 5 days after stopping parenteral iron therapy before taking oral iron supplements.
References
- "Product Information. Infed (iron dextran)." Schein Pharmaceuticals Inc
- (2001) "Product Information. Ferrlecit (sodium ferric gluconate complex)." sanofi-aventis
- (2001) "Product Information. Venofer (iron sucrose)." American Regent Laboratories Inc
- (2009) "Product Information. Feraheme (ferumoxytol)." Alza Pharmaceuticals
- (2021) "Product Information. Accrufer (ferric maltol)." Shield Therapeutics
Drug and food interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Iron preparations
Therapeutic duplication
The recommended maximum number of medicines in the 'iron preparations' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'iron preparations' category:
- Ferrlecit (sodium ferric gluconate complex)
- heme iron polypeptide
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.